Pdt Partners, LLC Biomarin Pharmaceutical Inc Transaction History

Pdt Partners, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $14,729 - $19,770	-182 Reduced 1.55%	11,574 $1.2 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $965,872 - $1.14 Million	11,756 New	11,756 $997,000
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $492,354 - $598,222	-6,888 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $511,640 - $638,448	6,888 New	6,888 $531,000
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $697,080 - $796,836	-9,323 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $703,979 - $790,497	9,323 New	9,323 $778,000
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $20.1 Million - $25.4 Million	-298,500 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $1.93 Million - $2.25 Million	23,995 Added 8.74%	298,500 $25.6 Million
Q1 2019 May 15, 2019	SELL	$84.2 - $98.62 $589 - $690	-7 Reduced -0.0%	274,505 $24.4 Million
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $961 - $1,272	12 Added 0.0%	274,512 $23.4 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $8.64 Million - $9.73 Million	-92,000 Reduced 25.1%	274,500 $26.6 Million
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $3,339 - $3,983	-43 Reduced 0.01%	366,500 $29.7 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $7.91 Million - $9.32 Million	97,943 Added 36.46%	366,543 $32.7 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $21.6 Million - $25.5 Million	268,600	268,600 $25 Million

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.